Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Suisse (CSUI) EBITDA Margin (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBITDA Margin for 8 consecutive years, with 876.36% as the latest value for Q1 2025.

  • For Q1 2025, EBITDA Margin fell 5236.0% year-over-year to 876.36%; the TTM value through Nov 2025 reached 3681.81%, down 265341.0%, while the annual FY2025 figure was 1261.2%, 41889.0% down from the prior year.
  • EBITDA Margin was 876.36% for Q1 2025 at Cannabis Suisse, up from 1216.64% in the prior quarter.
  • The five-year high for EBITDA Margin was 524.7% in Q4 2021, with the low at 6199.64% in Q1 2023.
  • Historically, EBITDA Margin has averaged 1399.72% across 4 years, with a median of 851.61% in 2023.
  • The largest annual shift saw EBITDA Margin tumbled -139436bps in 2021 before it surged 537564bps in 2024.
  • Over 4 years, EBITDA Margin stood at 524.7% in 2021, then decreased by -26bps to 661.88% in 2023, then crashed by -84bps to 1216.64% in 2024, then grew by 28bps to 876.36% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 876.36% in Q1 2025, 1216.64% in Q4 2024, and 983.71% in Q3 2024.